.png){kind=icon}
Return
Dengue
.png){kind=icon}
PRE
AI
DOI：10.1016/S0140-6736(23)02576-X.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Dengue, caused by four closely related viruses, is a growing global public health concern, with outbreaks capable of overwhelming health-care systems and disrupting economies. Dengue is endemic in more than 100 countries across tropical and subtropical regions worldwide, and the expanding range of the mosquito vector, affected in part by climate change, increases risk in new areas such as Spain, Portugal, and the southern USA, while emerging evidence points to silent epidemics in Africa. Substantial advances in our understanding of the virus, immune responses, and disease progression have been made within the past decade. Novel interventions have emerged, including partially effective vaccines and innovative mosquito control strategies, although a reliable immune correlate of protection remains a challenge for the assessment of vaccines. These developments mark the beginning of a new era in dengue prevention and control, offering promise in addressing this pressing global health issue.
Keywords:
ANTIBODY-DEPENDENT ENHANCEMENT
ZIKA VIRUS-INFECTION
HEMORRHAGIC-FEVER
VIETNAMESE CHILDREN
SHOCK SYNDROME
DISEASE
RISK
TRANSMISSION
POPULATION
PROTECTION
Journal
IF:
88.5
Papers:
5.4W
Citations:
34.8W
Organization
Cited Papers
.png){kind=icon}
ShareSaveShareSaveShareSave
View more